Cardiohemodynamic effect of FK409, a novel highly potent nitrovasodilator, in anesthetized dogs.
The cardiohemodynamic effect of (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409), a novel potent vasodilator, was studied in anesthetized open-chest dogs. FK409 (1 to 10 micrograms/kg, i.v.) decreased mean blood pressure, cardiac output and venous return (sum of the flow through the inferior and the superior vena cava). These changes accompanied decreases in left ventricular pressure, in its maximum rate of rise and in right atrial pressure. This cardiovascular profile of FK409 is very similar to those of classical nitrates.
Yamada
H
H
Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
Yoneyama
F
F
Satoh
K
K
Taira
N
N
D000777:Anesthetics; D000818:Animals; D004285:Dogs; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D009574:Nitro Compounds / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D000777:Anesthetics; D009574:Nitro Compounds; D014665:Vasodilator Agents; C061872:FK 409